Drug-resistant Plasmodium falciparum is a major threat to global malaria control and
elimination efforts. In Botswana, a southern African country approaching malaria elimination …

Partial artemisinin resistance has emerged in East Africa, posing a threat to malaria control
across the continent. The Democratic Republic of the Congo carries one of the heaviest …

Abstract Background Therapeutic efficacy studies (TESs) and detection of molecular
markers of drug resistance are recommended by the World Health Organization (WHO) to …

Objective Nigeria bears 25% of global malaria burden despite concerted efforts towards its
control and elimination. The emergence of drug resistance to first line drugs, artemisinin …

Resistance to the mainstay antimalarial drugs is a major concern in the control of malaria.
Delayed Plasmodium falciparum parasite clearance has been associated with Single …

One of the major obstacles to malaria elimination in the world is the resistance in
Plasmodium falciparum to most antimalarial drugs. This study aimed to estimate the …

In Suriname, an artesunate monotherapy therapeutic efficacy trial was recently conducted to
evaluate partial artemisinin resistance emerging in Plasmodium falciparum. We genotyped …

Background Molecular monitoring of parasite resistance has become an important
complementary tool in establishing rational anti-malarial drug policies. Community surveys …

Abstract Background The ability of Plasmodium falciparum parasites to develop resistance
to widely used anti-malarials threatens malaria control and elimination efforts. Regular drug …

Molecular markers for surveillance of Plasmodium falciparum resistance to current
antimalarials are sorely needed. A 28-day efficacy study of artemether-lumefantrine in …